AlzChem Group AG (ACT)
XETR
160.00
+1.90 (+1.20%)
Real-time Data
07:00 AM
Day's Range
158.50161.30
52 wk Range
123.20210.60
Financial Statements - ACT - AlzChem Group AG
Revenue
562.11M▲ 1.4%
Net Income
63.63M▲ 17.3%Net Margin 11.3%
EBITDA
119.56M▲ 11.2%
Free Cash Flow
137.01M▲ 30.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 562.11M | 554.23M | 540.64M | 542.22M | 422.29M | 379.25M |
| Cost of Goods | 172.37M | 193.50M | 224.08M | 259.49M | 153.95M | 128.67M |
| Gross Profit | 389.74M | 360.72M | 316.56M | 282.72M | 268.33M | 250.58M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 92.96M | 78.12M | 56.94M | 30.36M | 37.23M | 32.35M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 87.93M | 75.34M | 48.18M | 41.28M | 36.51M | 27.19M |
| Income Tax | 24.30M | 21.09M | 13.39M | 11.05M | 8.74M | 7.33M |
| Net Income | 63.63M | 54.24M | 34.79M | 30.22M | 27.76M | 19.86M |
| EPS Basic | 6.28 | 5.31 | 3.4 | 2.96 | 2.72 | 1.94 |
| EPS Diluted | 6.28 | 5.31 | 3.4 | 2.96 | 2.72 | 1.94 |
| Basic Shares Outstanding | 10.10M | 10.17M | 10.17M | 10.13M | 10.14M | 10.17M |
| Diluted Shares Outstanding | 10.10M | 10.17M | 10.17M | 10.13M | 10.14M | 10.17M |
| Ebit | 93.04M | 81.17M | 55.85M | 44.31M | 38.21M | 31.03M |
| Ebitda | 119.56M | 107.49M | 81.58M | 64.42M | 62.37M | 53.96M |
| Net Income Continuous Operations | 87.93M | 75.34M | 48.18M | 41.28M | 36.51M | 27.19M |
| Minority Interests | -171K | -171K | -171K | -171K | -171K | -171K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
